These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling? de Herder WW; Uitterlinden P; Pieterman H; Tanghe HL; Kwekkeboom DJ; Pols HA; Singh R; van de Berge JH; Lamberts SW Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486 [TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China. Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378 [TBL] [Abstract][Full Text] [Related]
6. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature. Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease. Fukuhara N; Inoshita N; Yamaguchi-Okada M; Tatsushima K; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H Endocr J; 2019 Mar; 66(3):259-264. PubMed ID: 30760659 [TBL] [Abstract][Full Text] [Related]
8. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging. Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414 [TBL] [Abstract][Full Text] [Related]
9. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease. Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121 [TBL] [Abstract][Full Text] [Related]
10. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission. Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716 [TBL] [Abstract][Full Text] [Related]
11. Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease. Mehta GU; Montgomery BK; Raghavan P; Sharma S; Nieman LK; Patronas N; Oldfield EH; Chittiboina P J Clin Neurosci; 2015 May; 22(5):891-4. PubMed ID: 25827866 [TBL] [Abstract][Full Text] [Related]
12. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results. López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446 [TBL] [Abstract][Full Text] [Related]
14. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921 [TBL] [Abstract][Full Text] [Related]
15. Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings. Ferrante E; Barbot M; Serban AL; Ceccato F; Carosi G; Lizzul L; Sala E; Daniele A; Indirli R; Cuman M; Locatelli M; Manara R; Arosio M; Boscaro M; Mantovani G; Scaroni C J Endocrinol Invest; 2022 Mar; 45(3):629-637. PubMed ID: 34699044 [TBL] [Abstract][Full Text] [Related]